Previous 10 | Next 10 |
Summary All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.3% and a median increase of 8.1%. There are thirty-two increases for next week, up from twenty-four last week. I've tr...
Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail Conference PR Newswire DUBLIN , March 2, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President an...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
Perrigo <<PRGO>> has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand OTC equivalent of Advil Dual Action Tablets 250 mg/125 mg. The Company anticipates launching t...
Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action Tablets PR Newswire DUBLIN , March 1, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products , today announced that i...
Perrigo Company ( NYSE: PRGO ) said its 2023 Non-GAAP EPS is expected to be between $2.50 - $2.70, vs. consensus of $2.72 . Reported EPS is expected to be in the range of $0.50 - $0.70. The company is set to share its 2023 to 2025 strategic plan and financial objectives i...
Perrigo Launches its 3-Year Optimize and Accelerate Strategic Plan, Issues Fiscal 2023 Guidance and Introduces 2025 Financial Targets at Investor Day PR Newswire DUBLIN , Feb. 28, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) announced that it will outlin...
Perrigo press release ( NYSE: PRGO ): Q4 Non-GAAP EPS of $0.75 beats by $0.04 . Revenue of $1.2B (+4.6% Y/Y) in-line. For further details see: Perrigo Non-GAAP EPS of $0.75 beats by $0.04, revenue of $1.2B in-line
Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations PR Newswire DUBLIN , Feb. 27, 2023 /PRNewswire/ -- ...
Perrigo ( NYSE: PRGO ) declares $0.273/share quarterly dividend , 5% increase from prior dividend of $0.26. Forward yield 3.0% Payable March 28; for shareholders of record March 10; ex-div March 9. See PRGO Dividend Scorecard, Yield Chart, & Dividend Growth. ...
News, Short Squeeze, Breakout and More Instantly...
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024 PR Newswire DUBLIN , July 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its secon...
2024-07-19 06:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire DUBLIN , July 10, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it has compl...